Opinion

Patrick Hwu: Honored to represent Moffitt Cancer Center at SITC24

Patrick Hwu/X

Nov 10, 2024, 03:05

Patrick Hwu: Honored to represent Moffitt Cancer Center at SITC24

Patrick Hwu, President and CEO at Moffitt Cancer Center, shared a post LinkedIn:

“Honored to be in Houston this week representing Moffitt Cancer Center alongside our team at SITC24, the largest cancer immunotherapy conference.

This is a gathering that’s important for us as scientists and clinicians but even more important for patients and families facing cancer. The breakthroughs discussed here have the potential to transform cancer care and improve patient outcomes.

Looking forward to connecting with friends and colleagues and learning and sharing through scientific exchange!”

More posts featuring Patrick Hwu on oncodaily.com

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.